Fat malabsorption in pancreatic cancer: Pathophysiology and management.
Murray G, Ramsey ML, Hart PA, Roberts KM.
Murray G, et al.
Nutr Clin Pract. 2024 Apr;39 Suppl 1:S46-S56. doi: 10.1002/ncp.11129.
Nutr Clin Pract. 2024.
PMID: 38429964
Review.
Together, these complications contribute to poor tolerance of oncologic therapies and negatively impact survival. Treatment of EPI in PDAC involves the addition of pancreatic enzyme replacement therapy, with titration to improve gastrointestinal symptoms. ...
Together, these complications contribute to poor tolerance of oncologic therapies and negatively impact survival. Treatment of EPI in PDAC …